vix.ing · top · new · best · stats · spec

Yves Pommier

  1. Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
    2012/10/31 by Junko Murai, Shar-yin N. Huang, Benu Brata Das +7 · 46 citations
    Medicine · Biochemistry, Genetics and Molecular Biology · Engineering · #PARP inhibition in cancer therapy #DNA Repair Mechanisms #Integrated Circuits and Semiconductor Failure Analysis
  2. DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
    2010/05/01 by Yves Pommier, Elisabetta Leo, Hongliang Zhang +1 · 10 citations
    Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer therapeutics and mechanisms #Neutropenia and Cancer Infections #Antibiotics Pharmacokinetics and Efficacy
  3. Synthesis of New Indeno[1,2-c]isoquinolines: Cytotoxic Non-Camptothecin Topoisomerase I Inhibitors
    2000/09/19 by Mark Cushman, Muthusamy Jayaraman, Jeffrey A. Vroman +5 · 15 citations
    Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics · #Cancer therapeutics and mechanisms #Bioactive Compounds and Antitumor Agents #Synthesis and bioactivity of alkaloids
  4. Structures of Three Classes of Anticancer Agents Bound to the Human Topoisomerase I−DNA Covalent Complex
    2005/02/24 by Bart L. Staker, M.D. Feese, Mark Cushman +4 · 18 citations
    Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer therapeutics and mechanisms #Antibiotics Pharmacokinetics and Efficacy #Lung Cancer Research Studies
  5. DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
    2009/05/29 by Yves Pommier · 8 citations
    Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer therapeutics and mechanisms #HIV/AIDS drug development and treatment #Synthesis and bioactivity of alkaloids
  6. Topoisomerase I inhibitors: camptothecins and beyond
    2006/09/22 by Yves Pommier · 13 citations
    Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer therapeutics and mechanisms #Lung Cancer Research Studies #Neutropenia and Cancer Infections
  7. Design, Synthesis, and Biological Evaluation of Indenoisoquinoline Topoisomerase I Inhibitors Featuring Polyamine Side Chains on the Lactam Nitrogen
    2003/11/21 by Muthukaman Nagarajan, Xiangshu Xiao, Smitha Antony +3 · 11 citations
    Biochemistry, Genetics and Molecular Biology · Chemistry · #Cancer therapeutics and mechanisms #Synthesis and Biological Evaluation #Synthesis and Biological Activity
  8. Topoisomerase I inhibitors: selectivity and cellular resistance
    1999/10/01 by Yves Pommier, Philippe Pourquier, Yoshimasa Urasaki +2 · 8 citations
    Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics · #Bioactive Compounds and Antitumor Agents #Cancer therapeutics and mechanisms #Neutropenia and Cancer Infections
  9. The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives
    2009/04/22 by Yves Pommier, Mark Cushman · 5 citations
    Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer therapeutics and mechanisms #Antibiotics Pharmacokinetics and Efficacy #Lung Cancer Research Studies
  10. Synthesis and Evaluation of Indenoisoquinoline Topoisomerase I Inhibitors Substituted with Nitrogen Heterocycles
    2006/09/26 by Muthukaman Nagarajan, Andrew Morrell, Alexandra Ioanoviciu +6 · 11 citations
    Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics · #Cancer therapeutics and mechanisms #Bioactive Compounds and Antitumor Agents #Synthesis and bioactivity of alkaloids
  11. Induction of a Common Pathway of Apoptosis by Staurosporine
    1994/04/01 by Richard Bertrand, Eric Solary, Éric Solary +4 · 28 citations
    Biochemistry, Genetics and Molecular Biology · Medicine · #Cell death mechanisms and regulation #Metal complexes synthesis and properties
  12. Synthesis and Mechanism of Action Studies of a Series of Norindenoisoquinoline Topoisomerase I Poisons Reveal an Inhibitor with a Flipped Orientation in the Ternary DNA−Enzyme−Inhibitor Complex As Determined by X-ray Crystallographic Analysis
    2005/06/23 by Alexandra Ioanoviciu, Smitha Antony, Yves Pommier +3 · 12 citations
    Biochemistry, Genetics and Molecular Biology · Chemistry · Pharmacology, Toxicology and Pharmaceutics · #Cancer therapeutics and mechanisms #Synthesis and biological activity #Bioactive Compounds and Antitumor Agents
  13. A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex
    2006/02/01 by Christophe Marchand, Smitha Antony, Kurt W. Kohn +6 · 5 citations
    Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics · Medicine · #Cancer therapeutics and mechanisms #Bioactive Compounds and Antitumor Agents #Neutropenia and Cancer Infections
  14. Nitrated Indenoisoquinolines as Topoisomerase I Inhibitors: A Systematic Study and Optimization
    2007/08/15 by Andrew Morrell, Michael S. Placzek, Seth Parmley +4 · 6 citations
    Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics · #Cancer therapeutics and mechanisms #Bioactive Compounds and Antitumor Agents #Synthesis and bioactivity of alkaloids
  15. Cellular Topoisomerase I Inhibition and Antiproliferative Activity by MJ-III-65 (NSC 706744), an Indenoisoquinoline Topoisomerase I Poison
    2004/11/06 by Smitha Antony, Glenda Kohlhagen, Keli Agama +6 · 6 citations
    Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics · #Bioactive Compounds and Antitumor Agents #Cancer therapeutics and mechanisms #Synthesis and bioactivity of alkaloids
  16. Design, Synthesis, and Biological Evaluation of 14-Substituted Aromathecins as Topoisomerase I Inhibitors
    2008/07/17 by Maris A. Cinelli, Andrew Morrell, Thomas S. Dexheimer +3 · 5 citations
    Biochemistry, Genetics and Molecular Biology · Chemistry · Pharmacology, Toxicology and Pharmaceutics · #Cancer therapeutics and mechanisms #Synthesis and biological activity #Bioactive Compounds and Antitumor Agents
  17. Novel Indenoisoquinolines NSC 725776 and NSC 724998 Produce Persistent Topoisomerase I Cleavage Complexes and Overcome Multidrug Resistance
    2007/11/01 by Smitha Antony, Keli Agama, Ze‐Hong Miao +8 · 5 citations
    Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics · #Cancer therapeutics and mechanisms #Synthesis and bioactivity of alkaloids #Bioactive Compounds and Antitumor Agents
  18. Optimization of the Indenone Ring of Indenoisoquinoline Topoisomerase I Inhibitors
    2007/08/04 by Andrew Morrell, Michael S. Placzek, Seth Parmley +4 · 6 citations
    Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics · #Cancer therapeutics and mechanisms #Synthesis and bioactivity of alkaloids #Bioactive Compounds and Antitumor Agents
  19. Synthesis and Biological Evaluation of Bisindenoisoquinolines as Topoisomerase I Inhibitors
    2006/07/28 by Muthukaman Nagarajan, Andrew Morrell, Smitha Antony +8 · 4 citations
    Biochemistry, Genetics and Molecular Biology · Chemistry · Pharmacology, Toxicology and Pharmaceutics · #Cancer therapeutics and mechanisms #Synthesis and biological activity #Bioactive Compounds and Antitumor Agents
  20. 4-Nitroquinoline-1-Oxide Induces the Formation of Cellular Topoisomerase I-DNA Cleavage Complexes
    2006/07/01 by Ze‐Hong Miao, V. Ashutosh Rao, Keli Agama +3 · 2 citations
    Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer therapeutics and mechanisms #DNA Repair Mechanisms #Acute Lymphoblastic Leukemia research
  21. Bisindenoisoquinoline Bis-1,3-(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylaminopropane bis(trifluoroacetate) (NSC 727357), a DNA Intercalator and Topoisomerase Inhibitor with Antitumor Activity
    2006/06/24 by Smitha Antony, Keli Agama, Keli K. Agama +11 · 4 citations
    Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics · #Bioactive Compounds and Antitumor Agents #Cancer therapeutics and mechanisms #Neutropenia and Cancer Infections
  22. Molecular Interaction Maps of Bioregulatory Networks: A General Rubric for Systems Biology
    2005/11/03 by Kurt W. Kohn, Mirit I. Aladjem, John N. Weinstein +1 · 5 citations
    Biochemistry, Genetics and Molecular Biology · #Gene Regulatory Network Analysis #Bioinformatics and Genomic Networks #Microbial Metabolic Engineering and Bioproduction
  23. Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay
    2006/06/06 by Andrew Morrell, Muthusamy Jayaraman, Muthukaman Nagarajan +8 · 4 citations
    Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer therapeutics and mechanisms #Neutropenia and Cancer Infections #Synthesis and bioactivity of alkaloids
  24. Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity
    2009/07/01 by Thomas D. Pfister, William C. Reinhold, Keli Agama +7 · 2 citations
    Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer therapeutics and mechanisms #Neuroblastoma Research and Treatments #Lung Cancer Research Studies
  25. Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription
    2009/10/18 by Sandie Tuduri, Laure Crabbé, Chiara Conti +11 · 1 citation
    Biochemistry, Genetics and Molecular Biology · #Cancer therapeutics and mechanisms #DNA Repair Mechanisms #Genomics and Chromatin Dynamics
  26. Structure-Based Design, Synthesis, and Biological Studies of New Anticancer Norindenoisoquinoline Topoisomerase I Inhibitors
    2010/02/15 by Yunlong Song, Zhiyu Shao, Thomas S. Dexheimer +3 · 1 citation
    Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics · #Cancer therapeutics and mechanisms #Lung Cancer Research Studies #Bioactive Compounds and Antitumor Agents
  27. Design, Synthesis, and Evaluation of Dibenzo[c,h][1,6]naphthyridines as Topoisomerase I Inhibitors and Potential Anticancer Agents
    2010/11/23 by Evgeny Kiselev, Thomas S. Dexheimer, Yves Pommier +1 · 1 citation
    Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics · #Cancer therapeutics and mechanisms #Bioactive Compounds and Antitumor Agents #Synthesis and bioactivity of alkaloids
  28. Depicting combinatorial complexity with the molecular interaction map notation
    2006/10/03 by Kurt W Kohn, Kurt W. Kohn, Mirit I Aladjem +5 · 1 citation
    Biochemistry, Genetics and Molecular Biology · Chemistry · Computer Science · #Computational Drug Discovery Methods #Gene Regulatory Network Analysis #History and advancements in chemistry
  29. The structure–activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode
    2010/06/21 by Maris A. Cinelli, Andrew Morrell, Andrew E. Morrell +5 · 1 citation
    Biochemistry, Genetics and Molecular Biology · Medicine · #Antibiotics Pharmacokinetics and Efficacy #Cancer therapeutics and mechanisms #Neutropenia and Cancer Infections
  30. Topoisomerase I Requirement for Death Receptor-induced Apoptotic Nuclear Fission
    2008/06/14 by Olivier Sordet, Abby R. Goldman, Christophe E. Redon +3 · 1 citation
    Biochemistry, Genetics and Molecular Biology · #Cancer therapeutics and mechanisms #Cell death mechanisms and regulation #DNA Repair Mechanisms
  31. Development of a Validated Immunofluorescence Assay for γH2AX as a Pharmacodynamic Marker of Topoisomerase I Inhibitor Activity
    2010/10/06 by Robert J. Kinders, Melinda G. Hollingshead, Scott M. Lawrence +9 · 1 citation
    Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer therapeutics and mechanisms #Colorectal Cancer Treatments and Studies #PARP inhibition in cancer therapy
  32. Camptothecins and Topoisomerase I; A Foot in the Door. Targeting the Genome Beyond Topoisomerase I with Camptothecins and Novel Anticancer Drugs; Importance of DNA Replication, Repair and Cell Cycle Checkpoints
    2004/09/01 by Yves Pommier · 2 citations
    Biochemistry, Genetics and Molecular Biology · Chemistry · Pharmacology, Toxicology and Pharmaceutics · #Cancer therapeutics and mechanisms #Synthesis of β-Lactam Compounds #Chemical Reactions and Isotopes
  33. Synthesis and biological evaluation of 14-(aminoalkyl-aminomethyl)aromathecins as topoisomerase I inhibitors: Investigating the hypothesis of shared structure–activity relationships
    2009/09/07 by Maris A. Cinelli, Brenda Cordero, Thomas S. Dexheimer +2 · 1 citation
    Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics · #Bioactive Compounds and Antitumor Agents #Cancer therapeutics and mechanisms #Neutropenia and Cancer Infections